HCW Biologics Inc. (HCWB) Earnings History
Annual and quarterly earnings data from 2019 to 2025
Loading earnings history...
HCWB EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
HCWB Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 20.0% | -20757.6% | -14677.1% |
| 2024 | 37.4% | -1148.5% | -1169.7% |
| 2023 | 19.7% | -905.0% | -879.5% |
| 2022 | 38.5% | -224.3% | -221.7% |
| 2021 | - | - | - |
Download Data
Export HCWB earnings history in CSV or JSON format
Free sign-in required to download data
HCW Biologics Inc. (HCWB) Earnings Overview
As of May 8, 2026, HCW Biologics Inc. (HCWB) reported trailing twelve-month net income of -$8M, reflecting -1280.5% year-over-year growth. The company earned $-3.79 per diluted share over the past four quarters, with a net profit margin of -14677.1%.
Looking at the long-term picture, HCWB's historical earnings data spans multiple years. The company achieved its highest annual net income of -$6M in fiscal 2020.
HCW Biologics Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including IMVT (-$464M net income), ARQT (-$2M net income, -4.3% margin), KYMR (-$315M net income, -794.4% margin), HCWB has comparable earnings metrics. Compare HCWB vs IMVT →
HCWB Earnings vs Peers
Earnings metrics vs comparable public companies
HCWB Historical Earnings Data (2019–2025)
7 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$8M | +73.5% | -$11M | $-10.63 | -14677.1% | -20757.6% |
| 2024 | -$30M | -20.1% | -$29M | $-0.77 | -1169.7% | -1148.5% |
| 2023 | -$25M | -67.7% | -$26M | $-0.70 | -879.5% | -905.0% |
| 2022 | -$15M | -15.8% | -$15M | $-0.41 | -221.7% | -224.3% |
| 2021 | -$13M | -122.5% | -$13M | $-0.35 | - | - |
| 2020 | -$6M | +20.7% | -$6M | $-0.16 | -141.0% | -142.1% |
| 2019 | -$7M | - | -$7M | $-0.20 | - | - |
See HCWB's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs HCWB Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare HCWB vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonHCWB — Frequently Asked Questions
Quick answers to the most common questions about buying HCWB stock.
Is HCWB growing earnings?
HCWB EPS fell to $-3.79, with earnings declining -1280.5%. This contrasts with the 5-year CAGR of N/A. TTM net income dropped to $-8M.
What are HCWB's profit margins?
HCW Biologics Inc. net margin is -14677.1%, with operating margin at -20757.6%. Below-average margins reflect competitive or cost pressures.
How consistent are HCWB's earnings?
HCWB earnings data spans 2019-2025. The declining earnings trend is -1280.5% YoY. Historical data enables comparison across business cycles.